Is Adagrasib (Krazati) prone to causing diarrhea and sharing of experience in dealing with side effects?

Adagrasib (trade name: Krazati) is a KRAS G12C inhibitor, mainly used to treat patients with non-small cell lung cancer harboring KRAS G12C mutations. Similar to other oral targeted drugs, adagrasib may also cause some adverse reactions while exerting anti-tumor effects, among which diarrhea is one of the more common side effects. Clinical research data shows that some patients will experience varying degrees of diarrhea during treatment, but most symptoms are mild to moderate and can usually be controlled through reasonable intervention.

The mechanism of diarrhea may be related to the effect of drugs on the epithelial cells of the digestive tract and changes in the balance of intestinal flora. Patients with mild diarrhea often only show an increase in the frequency of defecation and have little impact; however, if persistent or moderate to severe diarrhea occurs, it may lead to electrolyte imbalance, dehydration, and even affect medication compliance. Therefore, once patients find frequent diarrhea, they should promptly inform their doctors so that the medication regimen can be adjusted or symptomatic treatment can be added according to the situation.

In terms of diarrhea management, commonly used clinical measures include: maintaining adequate fluid intake and supplementing with oral rehydration salts to prevent dehydration; avoiding greasy, spicy, raw and cold foods in the diet, and choosing light, easy-to-digest meals; when necessary, doctors may prescribe antidiarrheal drugs, such as loperamide, etc., to relieve symptoms. In cases of severe diarrhea, doctors may also consider briefly discontinuing the medication or adjusting the dosage to ensure patient safety.

In addition to diarrhea, adagrasib may also cause side effects such as nausea, vomiting, fatigue, loss of appetite, and abnormal liver function. Patients should maintain close communication with their doctors during treatment, regularly monitor blood and liver and kidney function indicators, and provide timely feedback on their medication experience. Generally speaking, most side effects are manageable and reversible. Through the accumulation of scientific treatment experience, patients can minimize the impact on their quality of life while ensuring the curative effect.

Reference link:https://www.drugs.com